Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 26

1.

A murine monoclonal antibody to glycogen: characterization of epitope-fine specificity by saturation transfer difference (STD) NMR spectroscopy and its use in mycobacterial capsular α-glucan research.

van de Weerd R, Berbís MA, Sparrius M, Maaskant JJ, Boot M, Paauw NJ, de Vries N, Boon L, Baba O, Cañada FJ, Geurtsen J, Jiménez-Barbero J, Appelmelk BJ.

Chembiochem. 2015 Apr 13;16(6):977-89. doi: 10.1002/cbic.201402713. Epub 2015 Mar 12.

PMID:
25766777
2.

Structure and function of RNase AS, a polyadenylate-specific exoribonuclease affecting mycobacterial virulence in vivo.

Romano M, van de Weerd R, Brouwer FC, Roviello GN, Lacroix R, Sparrius M, van den Brink-van Stempvoort G, Maaskant JJ, van der Sar AM, Appelmelk BJ, Geurtsen JJ, Berisio R.

Structure. 2014 May 6;22(5):719-30. doi: 10.1016/j.str.2014.01.014. Epub 2014 Apr 3.

3.

Cyanovirin-N inhibits mannose-dependent Mycobacterium-C-type lectin interactions but does not protect against murine tuberculosis.

Driessen NN, Boshoff HI, Maaskant JJ, Gilissen SA, Vink S, van der Sar AM, Vandenbroucke-Grauls CM, Bewley CA, Appelmelk BJ, Geurtsen J.

J Immunol. 2012 Oct 1;189(7):3585-92. Epub 2012 Aug 31.

4.

Pyrazinoic acid decreases the proton motive force, respiratory ATP synthesis activity, and cellular ATP levels.

Lu P, Haagsma AC, Pham H, Maaskant JJ, Mol S, Lill H, Bald D.

Antimicrob Agents Chemother. 2011 Nov;55(11):5354-7. doi: 10.1128/AAC.00507-11. Epub 2011 Aug 29.

5.

Mycobacterium marinum MMAR_2380, a predicted transmembrane acyltransferase, is essential for the presence of the mannose cap on lipoarabinomannan.

Driessen NN, Stoop EJM, Ummels R, Gurcha SS, Mishra AK, Larrouy-Maumus G, Nigou J, Gilleron M, Puzo G, Maaskant JJ, Sparrius M, Besra GS, Bitter W, Vandenbroucke-Grauls CMJE, Appelmelk BJ.

Microbiology. 2010 Nov;156(Pt 11):3492-3502. doi: 10.1099/mic.0.037507-0. Epub 2010 Aug 5.

6.

Role of phosphatidylinositol mannosides in the interaction between mycobacteria and DC-SIGN.

Driessen NN, Ummels R, Maaskant JJ, Gurcha SS, Besra GS, Ainge GD, Larsen DS, Painter GF, Vandenbroucke-Grauls CM, Geurtsen J, Appelmelk BJ.

Infect Immun. 2009 Oct;77(10):4538-47. doi: 10.1128/IAI.01256-08. Epub 2009 Aug 3.

7.

The mannose cap of mycobacterial lipoarabinomannan does not dominate the Mycobacterium-host interaction.

Appelmelk BJ, den Dunnen J, Driessen NN, Ummels R, Pak M, Nigou J, Larrouy-Maumus G, Gurcha SS, Movahedzadeh F, Geurtsen J, Brown EJ, Eysink Smeets MM, Besra GS, Willemsen PT, Lowary TL, van Kooyk Y, Maaskant JJ, Stoker NG, van der Ley P, Puzo G, Vandenbroucke-Grauls CM, Wieland CW, van der Poll T, Geijtenbeek TB, van der Sar AM, Bitter W.

Cell Microbiol. 2008 Apr;10(4):930-44. Epub 2007 Dec 5.

PMID:
18070119
8.

Phase variation in H type I and Lewis a epitopes of Helicobacter pylori lipopolysaccharide.

Appelmelk BJ, Martino MC, Veenhof E, Monteiro MA, Maaskant JJ, Negrini R, Lindh F, Perry M, Del Giudice G, Vandenbroucke-Grauls CM.

Infect Immun. 2000 Oct;68(10):5928-32. Erratum in: Infect Immun 2000 Dec;68(12):7214.

9.

Phase variation in Helicobacter pylori lipopolysaccharide due to changes in the lengths of poly(C) tracts in alpha3-fucosyltransferase genes.

Appelmelk BJ, Martin SL, Monteiro MA, Clayton CA, McColm AA, Zheng P, Verboom T, Maaskant JJ, van den Eijnden DH, Hokke CH, Perry MB, Vandenbroucke-Grauls CM, Kusters JG.

Infect Immun. 1999 Oct;67(10):5361-6. Erratum in: Infect Immun 1999 Dec;67(12):6715.

10.

Anti-lipid A monoclonal antibody centoxin (HA-1A) binds to a wide variety of hydrophobic ligands.

Helmerhorst EJ, Maaskant JJ, Appelmelk BJ.

Infect Immun. 1998 Feb;66(2):870-3.

11.

Potential role of molecular mimicry between Helicobacter pylori lipopolysaccharide and host Lewis blood group antigens in autoimmunity.

Appelmelk BJ, Simoons-Smit I, Negrini R, Moran AP, Aspinall GO, Forte JG, De Vries T, Quan H, Verboom T, Maaskant JJ, Ghiara P, Kuipers EJ, Bloemena E, Tadema TM, Townsend RR, Tyagarajan K, Crothers JM Jr, Monteiro MA, Savio A, De Graaff J.

Infect Immun. 1996 Jun;64(6):2031-40.

12.

Diversity in lipid A binding ligands: comparison of lipid A monoclonal antibodies with rBPI23.

Appelmelk BJ, Qing AY, Helmerhorst EJ, Maaskant JJ, Abraham PR, Thijs LG, MacLaren DM.

Prog Clin Biol Res. 1995;392:453-63.

PMID:
8524952
13.

Antigenic and immunogenic differences in lipopolysaccharides of Escherichia coli J5 vaccine strains of different origins.

Appelmelk BJ, Maaskant JJ, Verweij-van Vught AM, van der Meer NM, Thijs BG, MacLaren DM.

J Gen Microbiol. 1993 Nov;139(11):2641-7.

PMID:
7506295
14.

Enhancement of complement-mediated killing of Neisseria gonorrhoeae by antibodies to lipopolysaccharide of Escherichia coli J5.

Appelmelk BJ, Verweij-van Vught M, Maaskant JJ, Thijs BG, Maclaren DM.

J Infect Dis. 1993 Mar;167(3):773-5. No abstract available.

PMID:
8499020
15.

Murine ascitic fluids contain varying amounts of an inhibitor that interferes with complement-mediated effector functions of monoclonal antibodies.

Appelmelk BJ, Verweij-Van Vught AM, Maaskant JJ, Thijs LG, MacLaren DM.

Immunol Lett. 1992 Jul;33(2):135-8.

PMID:
1280247
16.

Further characterization of monoclonal antibodies to lipopolysaccharide of Salmonella Minnesota strain R595.

Appelmelk BJ, Cohen J, Silva A, Verweij-van Vught AM, Brade H, Maaskant JJ, Schouten WF, Mol O, Honing A, Thijs LG, et al.

Adv Exp Med Biol. 1990;256:319-30.

PMID:
2109505
17.

Comparison of monoclonal antibodies to the deeper core region of gram-negative lipopolysaccharide by means of polymyxin B inhibition studies.

Appelmelk BJ, Verweij-van Vught AM, Maaskant JJ, Schouten WF, Thijs LG, MacLaren DM.

Microb Pathog. 1988 Oct;5(4):297-301.

PMID:
2853278
18.

Prevention of lethal endotoxemia in actinomycin D-sensitized mice by incubation of Salmonella minnesota R595 lipopolysaccharide with monoclonal antibodies to R595.

Appelmelk BJ, Verweij-van Vught AM, Brade H, Maaskant JJ, Schouten WF, Thijs LG, MacLaren DM.

Microb Pathog. 1988 Oct;5(4):251-7.

PMID:
2467166
19.

Production and characterisation of mouse monoclonal antibodies reacting with the lipopolysaccharide core region of gram-negative bacilli.

Appelmelk BJ, Verweij-van Vught AM, Maaskant JJ, Schouten WF, De Jonge AJ, Thijs LG, Maclaren DM.

J Med Microbiol. 1988 Jun;26(2):107-14.

PMID:
2455054
20.

Heterogeneity of Escherichia coli J5 vaccines.

Appelmelk BJ, Rapson NT, Verweij-van Vught AM, Maaskant JJ, Hekker TA, Peerbooms PG, MacLaren DM, Thijs LG.

Lancet. 1986 Nov 29;2(8518):1273-4. No abstract available.

PMID:
2878147
21.

Cross-reactivity of antibodies to lipopolysaccharides from Escherichia coli J5.

Appelmelk BJ, Verweij-van Vught AM, Maaskant JJ, Thijs LG, MacLaren DM.

J Infect Dis. 1986 Sep;154(3):538-9. No abstract available.

PMID:
3525700
22.

Use of mucin and hemoglobin in experimental murine gram-negative bacteremia enhances the immunoprotective action of antibodies reactive with the lipopolysaccharide core region.

Appelmelk BJ, Verwey-van Vught AM, Maaskant JJ, Schouten WF, Thijs LG, Maclaren DM.

Antonie Van Leeuwenhoek. 1986;52(6):537-42.

PMID:
3545072
24.

Direct effects of the hyperglycemic factor of the freshwater snail Lymnaea stagnalis on isolated glycogen cells.

Hemminga MA, Maaskant JJ, Joosse J.

Gen Comp Endocrinol. 1985 Apr;58(1):131-6.

PMID:
3988032
25.

Different subpopulations of haemocytes in juvenile, adult and Trichobilharzia ocellata infected Lymnaea stagnalis: a characterization using monoclonal antibodies.

Dikkeboom R, van der Knaap WP, Maaskant JJ, de Jonge AJ.

Z Parasitenkd. 1985;71(6):815-9. No abstract available.

PMID:
4082736
26.

Neuroendocrine control of glycogen mobilization in the freshwater snail Lymnaea stagnalis.

Hemminga MA, Maaskant JJ, Koomen W, Joosse J.

Gen Comp Endocrinol. 1985 Jan;57(1):117-23.

PMID:
3972239

Supplemental Content

Loading ...
Support Center